Spontaneous aortic thrombosis and embolization: antithrombin deficiency and the work-up of hypercoagulable states

Marcu, Constantin B.; Donohue, Thomas J.; Ghantous, Andre E.
October 2005
CMAJ: Canadian Medical Association Journal;10/25/2005, Vol. 173 Issue 9, p1027
Academic Journal
Discusses the case of a 24-year-old man with sudden onset of severe periumbilical and right costovertebral pain accompanied by nausea and vomiting. Medical history of the patient; Conditions and coagulation defects associated with thrombosis; Factors to consider in patients with suspected hypercoagulable disorder.


Related Articles

  • Stability of an extemporaneous oral liquid aprepitant formulation. Karen Lingertat-Walsh // Supportive Care in Cancer;Jun2009, Vol. 17 Issue 6, p701 

    Abstract Goals of work  Aprepitant is currently recommended for the prevention of acute antineoplastic-induced nausea and vomiting in adults receiving highly emetogenic therapy. The lack of an oral liquid dosage form is one barrier to its use in children. The purpose of this study was to...

  • Do current antiemetic practices result in positive patient outcomes? Results of a new study. Wender, Ronald H. // American Journal of Health-System Pharmacy;1/2/2009, Vol. 66 Issue S1, pS3 

    Purpose. The problem of perioperative nausea and vomiting (including postoperative and postdischarge nausea and vomiting [PONV/PDNV]) among people undergoing general anesthesia is discussed. Summary. Nausea and vomiting are not limited to the postanesthesia care unit (PACU) or the hospital, but...

  • A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting. Xiao-fei Wang; Yun Feng; Ying Chen; Bei Li Gao; Bao-hui Han // Scientific Reports;5/2/2014, p1 

    Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life and is one of the reasons for the discontinuation of treatment. Olanzapine is known as an atypical antipsychotic agent, but it has been reported to be effective in treating...

  • Metoclopramide Infusion with a Disposable Portable Pump. Brufra, Eduardo; Macdonald, Neil; Brenneis, Carleen; Simpson, Lain; LeGatt, Donald // Annals of Internal Medicine;Jun86, Vol. 104 Issue 6, p896 

    Presents information on the preliminary result of a study that used metoclopramide infusion with a disposable portable pump in the treatment of patients with advanced cancer who had chronic nausea and vomiting. Purpose of the oral metoclopramide received by the patients; Benefits of using the...

  • Consensus guide on preventing PONV.  // OR Manager;Dec2006, Vol. 22 Issue 12, p18 

    The article discusses the guideline on postoperative nausea and vomiting and postdischarge nausea and vomiting from the American Society of PeriAnesthesia Nurses. The guideline sorts out the evidence on application of antiemetics, anesthesia techniques and complementary therapy. The guideline...

  • Chemotherapy-Induced Nausea and Vomiting. Rittenberg, Cynthia; Cunningham, Regina S.; Hogle, William P. // Clinical Journal of Oncology Nursing;Apr2005, Vol. 9 Issue 2, p257 

    Provides answers to questions on chemotherapy-induced nausea and vomiting.

  • Paracetamol overdose.  // Reactions Weekly;4/19/2008, Issue 1198, p35 

    The article describes the case of a 25-year-old man who experienced nausea, vomiting and mild coagulopathy after paracetamol overdose in a suicide attempt. After the overdose, she was taken to the hospital. She was given antiemetics and intravenous (IV) acetylcysteine. Acetylcysteine was stopped...

  • Anticipatory nausea in cyclical vomiting. McRonald, Fiona E.; Fleisher, David R. // BMC Pediatrics;2005, Vol. 5, p3 

    Background: Cyclical Vomiting Syndrome (CVS) is characterised by discrete, unexplained episodes of intense nausea and vomiting, and mainly affects children and adolescents. Comprehending Cyclical Vomiting Syndrome requires awareness of the severity of nausea experienced by patients. As a...

  • A Phase 3, randomized, double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting: Results of an Indian population subanalysis. Maru, A.; Gangadharan, V. P.; Desai, C. J.; Mohapatra, R. K.; Carides, A. D. // Indian Journal of Cancer;Oct-Dec2013, Vol. 50 Issue 4, p285 

    CONTEXT: Currently, there is limited data on the prevention of chemotherapy-induced nausea and vomiting (CINV) in Indian patients. AIMS: This post hoc study assessed the efficacy and safety of fosaprepitant compared with aprepitant for prevention of CINV in the Indian population. A subgroup...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics